Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: Pharmacia Limited Ramsgate Road Sandwich Kent CT13 9NJ UK
Solu-Cortef 100 mg or Hydrocortisone sodium succinate for injection BP 100 mg.
| Pharmaceutical Form |
|---|
|
White, freeze dried powder for parenteral use. |
Each vial contains Hydrocortisone sodium succinate 133.7 mg equivalent to hydrocortisone 100.0 mg.
| Active Ingredient | Description | |
|---|---|---|
| Hydrocortisone |
Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. |
| List of Excipients |
|---|
|
Sodium biphosphate |
Type I flint glass vials with a butyl rubber plug and metal seal. Each vial of Solu-Cortef 100 mg contains the equivalent of 100 mg hydrocortisone as the sodium succinate for reconstitution with 2 ml of Sterile Water for Injections.
Pharmacia Limited
Ramsgate Road
Sandwich
Kent
CT13 9NJ
UK
PL 0032/5019
Date of first authorisation (PL 0032/5019): 18 May 1990
Last renewal date: 15 March 2005
| Drug | Countries | |
|---|---|---|
| SOLU-CORTEF | Australia, Canada, Estonia, Finland, Hong Kong, Croatia, Ireland, Israel, Japan, Malta, Netherlands, New Zealand, Singapore, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
